Search

Anne Marie Falk

Examiner (ID: 427)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
685
Issued Applications
242
Pending Applications
153
Abandoned Applications
292

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6755312 [patent_doc_number] => 20030003089 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Tissue engineered cardiac constructs' [patent_app_type] => new [patent_app_number] => 10/141768 [patent_app_country] => US [patent_app_date] => 2002-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7949 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20030003089.pdf [firstpage_image] =>[orig_patent_app_number] => 10141768 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/141768
Tissue engineered cardiac constructs May 9, 2002 Abandoned
Array ( [id] => 586049 [patent_doc_number] => 07446239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => 'SCA2 knockout animal and methods of use' [patent_app_type] => utility [patent_app_number] => 10/141541 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10273 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446239.pdf [firstpage_image] =>[orig_patent_app_number] => 10141541 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/141541
SCA2 knockout animal and methods of use May 6, 2002 Issued
Array ( [id] => 6792516 [patent_doc_number] => 20030087860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Methods for sexing non-human mammals' [patent_app_type] => new [patent_app_number] => 10/137706 [patent_app_country] => US [patent_app_date] => 2002-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4479 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087860.pdf [firstpage_image] =>[orig_patent_app_number] => 10137706 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/137706
Methods for sexing non-human mammals May 2, 2002 Abandoned
Array ( [id] => 6869999 [patent_doc_number] => 20030082688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Spoil protein and nucleic acid molecules and uses therefor' [patent_app_type] => new [patent_app_number] => 10/126560 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 44429 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082688.pdf [firstpage_image] =>[orig_patent_app_number] => 10126560 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/126560
Spoil protein and nucleic acid molecules and uses therefor Apr 18, 2002 Abandoned
Array ( [id] => 6846267 [patent_doc_number] => 20030165434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Delivery of polynucleotide agents to the central nervous system' [patent_app_type] => new [patent_app_number] => 10/126060 [patent_app_country] => US [patent_app_date] => 2002-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25762 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20030165434.pdf [firstpage_image] =>[orig_patent_app_number] => 10126060 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/126060
Delivery of polynucleotide agents to the central nervous system Apr 18, 2002 Abandoned
Array ( [id] => 6741789 [patent_doc_number] => 20030159158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders' [patent_app_type] => new [patent_app_number] => 10/124334 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29033 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20030159158.pdf [firstpage_image] =>[orig_patent_app_number] => 10124334 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/124334
Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders Apr 16, 2002 Issued
Array ( [id] => 5859840 [patent_doc_number] => 20020123467 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-05 [patent_title] => 'Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury' [patent_app_type] => new [patent_app_number] => 10/119714 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 15441 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20020123467.pdf [firstpage_image] =>[orig_patent_app_number] => 10119714 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/119714
Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury Apr 10, 2002 Abandoned
Array ( [id] => 748593 [patent_doc_number] => 07022321 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-04 [patent_title] => 'Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system' [patent_app_type] => utility [patent_app_number] => 10/122703 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 6058 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022321.pdf [firstpage_image] =>[orig_patent_app_number] => 10122703 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/122703
Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system Apr 10, 2002 Issued
Array ( [id] => 6261718 [patent_doc_number] => 20020187921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Transgenic zebrafish models for neurodegenerative disease' [patent_app_type] => new [patent_app_number] => 10/116723 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13986 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187921.pdf [firstpage_image] =>[orig_patent_app_number] => 10116723 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/116723
Transgenic zebrafish models for neurodegenerative disease Apr 3, 2002 Abandoned
Array ( [id] => 6774667 [patent_doc_number] => 20030018005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Gene therapy of diseases associated with the immune system, using a cell-specific active compound which is regulated by the cell cycle' [patent_app_type] => new [patent_app_number] => 10/112953 [patent_app_country] => US [patent_app_date] => 2002-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 22852 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018005.pdf [firstpage_image] =>[orig_patent_app_number] => 10112953 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/112953
Gene therapy of diseases associated with the immune system, using a cell-specific active compound which is regulated by the cell cycle Apr 1, 2002 Abandoned
Array ( [id] => 6813550 [patent_doc_number] => 20030073100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Method of identifying renalgenerative agents using differential gene expression' [patent_app_type] => new [patent_app_number] => 10/113312 [patent_app_country] => US [patent_app_date] => 2002-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8440 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0073/20030073100.pdf [firstpage_image] =>[orig_patent_app_number] => 10113312 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/113312
Method of identifying renalgenerative agents using differential gene expression Mar 31, 2002 Abandoned
Array ( [id] => 6720652 [patent_doc_number] => 20030054340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-20 [patent_title] => 'Neural tracing with a conditional herpesvirus and methods and uses thereof' [patent_app_type] => new [patent_app_number] => 10/109534 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18836 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20030054340.pdf [firstpage_image] =>[orig_patent_app_number] => 10109534 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/109534
Neural tracing with a conditional herpesvirus and methods and uses thereof Mar 27, 2002 Abandoned
Array ( [id] => 6752194 [patent_doc_number] => 20030046715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'H2-O modified transgenic animals' [patent_app_type] => new [patent_app_number] => 10/109165 [patent_app_country] => US [patent_app_date] => 2002-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12283 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20030046715.pdf [firstpage_image] =>[orig_patent_app_number] => 10109165 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/109165
H2-O modified transgenic animals Mar 26, 2002 Abandoned
Array ( [id] => 363692 [patent_doc_number] => 07482506 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Ras p27 mouse models and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/472057 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 6905 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482506.pdf [firstpage_image] =>[orig_patent_app_number] => 10472057 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/472057
Ras p27 mouse models and uses thereof Mar 25, 2002 Issued
Array ( [id] => 6402431 [patent_doc_number] => 20020182192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Methods for treating muscular dystrophy' [patent_app_type] => new [patent_app_number] => 10/100268 [patent_app_country] => US [patent_app_date] => 2002-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7792 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20020182192.pdf [firstpage_image] =>[orig_patent_app_number] => 10100268 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/100268
Methods for treating muscular dystrophy Mar 13, 2002 Abandoned
Array ( [id] => 6110330 [patent_doc_number] => 20020172664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-21 [patent_title] => 'Methods of treating Parkinson\'s disease using recombinant adeno-associated virus virions' [patent_app_type] => new [patent_app_number] => 10/096723 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6761 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20020172664.pdf [firstpage_image] =>[orig_patent_app_number] => 10096723 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/096723
Methods of treating Parkinson's disease using recombinant adeno-associated virus virions Mar 12, 2002 Issued
Array ( [id] => 6051890 [patent_doc_number] => 20020170078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Calcineurin-related transgenic mammals, compositions and methods' [patent_app_type] => new [patent_app_number] => 10/091714 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12241 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20020170078.pdf [firstpage_image] =>[orig_patent_app_number] => 10091714 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/091714
Calcineurin-related transgenic mammals, compositions and methods Mar 4, 2002 Abandoned
Array ( [id] => 6741797 [patent_doc_number] => 20030159166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'H2-O modified transgenic animals' [patent_app_type] => new [patent_app_number] => 10/085297 [patent_app_country] => US [patent_app_date] => 2002-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12286 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20030159166.pdf [firstpage_image] =>[orig_patent_app_number] => 10085297 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/085297
H2-O modified transgenic animals Feb 27, 2002 Abandoned
Array ( [id] => 5905779 [patent_doc_number] => 20020142338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'Compositions and methods for inhibiting motor neuron degeneration' [patent_app_type] => new [patent_app_number] => 10/082032 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11583 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142338.pdf [firstpage_image] =>[orig_patent_app_number] => 10082032 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/082032
Compositions and methods for inhibiting motor neuron degeneration Feb 20, 2002 Abandoned
Array ( [id] => 6802503 [patent_doc_number] => 20030097668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Compositions and methods for the treatment and diagnosis of cardiovascular disease' [patent_app_type] => new [patent_app_number] => 10/067741 [patent_app_country] => US [patent_app_date] => 2002-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 48198 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0097/20030097668.pdf [firstpage_image] =>[orig_patent_app_number] => 10067741 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/067741
Compositions and methods for the treatment and diagnosis of cardiovascular disease Feb 7, 2002 Abandoned
Menu